|
1
|
Pappachan JM, Babu S, Krishnan B and
Ravindran NC: Non-alcoholic fatty liver disease: A clinical update.
J Clin Transl Hepatol. 5:384–393. 2017.PubMed/NCBI
|
|
2
|
Younossi ZM, Koenig AB, Abdelatif D, Fazel
Y, Henry L and Wymer M: Global epidemiology of nonalcoholic fatty
liver disease-Meta-analytic assessment of prevalence, incidence,
and outcomes. Hepatology. 64:73–84. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Tacke F: Targeting hepatic macrophages to
treat liver diseases. J Hepatol. 66:1300–1312. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Park JK, Shao M, Kim MY, Baik SK, Cho MY,
Utsumi T, Satoh A, Ouyang X, Chung C and Iwakiri Y: An endoplasmic
reticulum protein, Nogo-B, facilitates alcoholic liver disease
through regulation of kupffer cell polarization. Hepatology.
65:1720–1734. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Baeck C, Wehr A, Karlmark KR, Heymann F,
Vucur M, Gassler N, Huss S, Klussmann S, Eulberg D, Luedde T, et
al: Pharmacological inhibition of the chemokine CCL2 (MCP-1)
diminishes liver macrophage infiltration and steatohepatitis in
chronic hepatic injury. Gut. 61:416–426. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Liaskou E, Zimmermann HW, Li KK, Oo YH,
Suresh S, Stamataki Z, Qureshi O, Lalor PF, Shaw J, Syn WK, et al:
Monocyte subsets in human liver disease show distinct phenotypic
and functional characteristics. Hepatology. 57:385–398. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Song JJ, Celeste AJ, Kong FM, Jirtle RL,
Rosen V and Thies RS: Bone morphogenetic protein-9 binds to liver
cells and stimulates proliferation. Endocrinology. 136:4293–4297.
1995. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Brown MA, Zhao Q, Baker KA, Naik C, Chen
C, Pukac L, Singh M, Tsareva T, Parice Y, Mahoney A, et al: Crystal
structure of BMP-9 and functional interactions with pro-region and
receptors. J Biol Chem. 280:25111–25118. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
David L, Mallet C, Keramidas M, Lamandé N,
Gasc JM, Dupuis-Girod S, Plauchu H, Feige JJ and Bailly S: Bone
morphogenetic protein-9 is a circulating vascular quiescence
factor. Circ Res. 102:914–922. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Herrera B, Dooley S and Breitkopf-Heinlein
K: Potential roles of bone morphogenetic protein (BMP)-9 in human
liver diseases. Int J Mol Sci. 15:5199–5220. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Bessa PC, Cerqueira MT, Rada T, Gomes ME,
Neves NM, Nobre A, Reis RL and Casal M: Expression, purification
and osteogenic bioactivity of recombinant human BMP-4, −9, −10, −11
and −14. Protein Expr Purif. 63:89–94. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chen C, Grzegorzewski KJ, Barash S, Zhao
Q, Schneider H, Wang Q, Singh M, Pukac L, Bell AC, Duan R, et al:
An integrated functional genomics screening program reveals a role
for BMP-9 in glucose homeostasis. Nat Biotechnol. 21:294–301. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Suzuki Y, Ohga N, Morishita Y, Hida K,
Miyazono K and Watabe T: BMP-9 induces proliferation of multiple
types of endothelial cells in vitro and in vivo. J Cell Sci.
123:1684–1692. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Truksa J, Peng H, Lee P and Beutler E:
Bone morphogenetic proteins 2, 4, and 9 stimulate murine hepcidin 1
expression independently of Hfe, transferrin receptor 2 (Tfr2), and
IL-6. Proc Natl Acad Sci U S A. 103:10289–10293. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Li Q, Gu X, Weng H, Ghafoory S, Liu Y,
Feng T, Dzieran J, Li L, Ilkavets I, Kruithof-de Julio M, et al:
Bone morphogenetic protein-9 induces epithelial to mesenchymal
transition in hepatocellular carcinoma cells. Cancer Sci.
104:398–408. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Herrera B, Garcia-Alvaro M, Cruz S, Walsh
P, Fernández M, Roncero C, Fabregat I, Sánchez A and Inman GJ: BMP9
is a proliferative and survival factor for human hepatocellular
carcinoma cells. PLoS One. 8:e695352013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kuo MM, Kim S, Tseng CY, Jeon YH, Choe S
and Lee DK: BMP-9 as a potent brown adipogenic inducer with
anti-obesity capacity. Biomaterials. 35:3172–3179. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Young K, Tweedie E, Conley B, Ames J,
FitzSimons M, Brooks P, Liaw L and Vary CP: BMP9 crosstalk with the
hippo pathway regulates endothelial cell matricellular and
chemokine responses. PloS One. 10:e01228922015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Breitkopf-Heinlein K, Meyer C, Konig C,
Gaitantzi H, Addante A, Thomas M, Wiercinska E, Cai C, Li Q, Wan F,
et al: BMP-9 interferes with liver regeneration and promotes liver
fibrosis. Gut. 66:939–954. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kim S, Choe S and Lee DK: BMP-9 enhances
fibroblast growth factor 21 expression and suppresses obesity.
Biochim Biophys Acta. 1862:1237–1246. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Chen LL, Yang WH, Zheng J, Hu X, Kong W
and Zhang HH: Effect of catch-up growth after food restriction on
the entero-insular axis in rats. Nutr Metab(Lond). 7:452010.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Bedossa P, Poitou C, Veyrie N, Bouillot
JL, Basdevant A, Paradis V, Tordjman J and Clement K:
Histopathological algorithm and scoring system for evaluation of
liver lesions in morbidly obese patients. Hepatology. 56:1751–1759.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kleiner DE, Brunt EM, Van Natta M, Behling
C, Contos MJ, Cummings OW, Ferrell LD, Liu YC, Torbenson MS,
Unalp-Arida A, et al: Design and validation of a histological
scoring system for nonalcoholic fatty liver disease. Hepatology.
41:1313–1321. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Pierantonelli I and Svegliati-Baroni G:
Nonalcoholic fatty liver disease: Basic pathogenetic mechanisms in
the progression from NAFLD to NASH. Transplantation. 103:e1–e13.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Li P, Li Y, Zhu L, Yang Z, He J, Wang L,
Shang Q, Pan H, Wang H, Ma X, et al: Targeting secreted cytokine
BMP9 gates the attenuation of hepatic fibrosis. Biochim Biophys
Acta Mol Basis Dis. 1864:709–720. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Flores-Costa R, Alcaraz-Quiles J, Titos E,
López-Vicario C, Casulleras M, Duran-Güell M, Rius B, Diaz A, Hall
K, Shea C, et al: The soluble guanylate cyclase stimulator IW-1973
prevents inflammation and fibrosis in experimental non-alcoholic
steatohepatitis. Br J Pharmacol. 175:953–967. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Roderfeld M: Matrix metalloproteinase
functions in hepatic injury and fibrosis. Matrix Biol.
68-69:452–462. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Berres ML, Nellen A and Wasmuth HE:
Chemokines as immune mediators of liver diseases related to the
metabolic syndrome. Dig Dis. 28:192–196. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Deshmane SL, Kremlev S, Amini S and Sawaya
BE: Monocyte chemoattractant protein-1 (MCP-1): An overview. J
Interferon Cytokine Res. 29:313–326. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Upton PD, Davies RJ, Trembath RC and
Morrell NW: Bone morphogenetic protein (BMP) and activin type II
receptors balance BMP9 signals mediated by activin receptor-like
kinase-1 in human pulmonary artery endothelial cells. J Biol Chem.
284:15794–15804. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Appleby SL, Mitrofan CG, Crosby A,
Hoenderdos K, Lodge K, Upton PD, Yates CM, Nash GB, Chilvers ER and
Morrell NW: Bone morphogenetic protein 9 enhances
lipopolysaccharide-induced leukocyte recruitment to the vascular
endothelium. J Immunol. 197:3302–3314. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Young K, Conley B, Romero D, Tweedie E,
O'Neill C, Pinz I, Brogan L, Lindner V, Liaw L and Vary CP: BMP9
regulates endoglin-dependent chemokine responses in endothelial
cells. Blood. 120:4263–4273. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Rocher C and Singla DK: SMAD-PI3K-Akt-mTOR
pathway mediates BMP-7 polarization of monocytes into M2
macrophages. PloS One. 8:e840092013. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Martínez VG, Rubio C, Martinez-Fernandez
M, Segovia C, López-Calderón F, Garín MI, Teijeira A,
Munera-Maravilla E, Varas A, Sacedón R, et al: BMP4 induces M2
macrophage polarization and favors tumor progression in Bladder
cancer. Clin Cancer Res. 23:7388–7399. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Moore LB, Sawyer AJ, Charokopos A, Skokos
EA and Kyriakides TR: Loss of monocyte chemoattractant protein-1
alters macrophage polarization and reduces NFkappaB activation in
the foreign body response. Acta Biomater. 11:37–47. 2015.
View Article : Google Scholar : PubMed/NCBI
|
